Unique ID issued by UMIN | UMIN000050812 |
---|---|
Receipt number | R000057905 |
Scientific Title | Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease |
Date of disclosure of the study information | 2023/04/11 |
Last modified on | 2024/01/09 14:08:54 |
Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease
Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease
Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease
Relationship between the effect of roxadustat and comorbidity of diabetes in non-dialysis patients with chronic kidney disease
Japan |
renal anemia, chronic kidney disease, diabetes mellitus
Medicine in general | Endocrinology and Metabolism | Nephrology |
Others
NO
Retrospective study to determine the factors influencing the efficacy of roxadustat in non-dialysis CKD patients, with a particular focus on comorbid diabetes.
Safety,Efficacy
Exploratory
The changes in the dose over 6 months after initiation of roxadustat
Changes in hemoglobin levels and achievement rates of target hemoglobin levels over 6 months after initiation of roxadustat
Observational
Not applicable |
Not applicable |
Male and Female
Non-dialysis patients with chronic kidney disease and renal anemia
Patients who were transferred to another hospital within a month after the initiation of roxadustat
Patients whose hemoglobin level of 11 g/dL or higher at the initiation of roxadustat
40
1st name | Hiroyuki |
Middle name | |
Last name | Ito |
Edogawa Hospital
Department of Diabetes, Metabolism and Kidney Disease
133-0052
2-24-18, Higashikoiwa, Edogawa-ku, Tokyo
03-3673-1221
ito@edogawa.or.jp
1st name | Hiroyuki |
Middle name | |
Last name | Ito |
Edogawa Hospital
Department of Diabetes, Metabolism and Kidney Disease
133-0052
2-24-18, Higashikoiwa, Edogawa-ku, Tokyo
03-3673-1221
ito@edogawa.or.jp
Edogawa Hospital
none
Self funding
Edogawa Hospital
2-24-18, Higashikoiwa, Edogawa-ku, Tokyo
03-3673-1221
ito@edogawa.or.jp
NO
2023 | Year | 04 | Month | 11 | Day |
https://www.cureus.com/articles/156342-relationship-between-the-effect-of-roxadustat-and-comorbid-di
Published
https://www.cureus.com/articles/156342-relationship-between-the-effect-of-roxadustat-and-comorbid-di
44
The comorbidities of DM and BW at baseline were significantly associated with each dose of ROX at 6 M and the change in each dose of ROX. There was no difference in the amount of increase in the Hb level and the rate of Hb target achievement between patients with and without DM. Each dose of ROX gradually decreased in patients without DM, whereas it increased in those with DM. Each dose of ROX was significantly higher in patients with DM than in those without DM at 3 and 6 M after the initiation of ROX.
2024 | Year | 01 | Month | 09 | Day |
2023 | Year | 05 | Month | 26 | Day |
44 patients with chronic kidney disease treated using roxadustat
44 patients with chronic kidney disease treated using roxadustat
Adverse events were found in 9 patients
Hb, dose of roxadustat
Main results already published
2021 | Year | 08 | Month | 02 | Day |
2021 | Year | 08 | Month | 02 | Day |
2021 | Year | 08 | Month | 02 | Day |
2022 | Year | 07 | Month | 31 | Day |
retrospective observation study
2023 | Year | 04 | Month | 11 | Day |
2024 | Year | 01 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057905
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |